278 related articles for article (PubMed ID: 2123889)
1. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
Houglum K; Filip M; Witztum JL; Chojkier M
J Clin Invest; 1990 Dec; 86(6):1991-8. PubMed ID: 2123889
[TBL] [Abstract][Full Text] [Related]
2. Protein adducts of malondialdehyde and 4-hydroxynonenal in livers of iron loaded rats: quantitation and localization.
Khan MF; Wu X; Tipnis UR; Ansari GA; Boor PJ
Toxicology; 2002 May; 173(3):193-201. PubMed ID: 11960672
[TBL] [Abstract][Full Text] [Related]
3. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
4. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization.
Hartley DP; Kolaja KL; Reichard J; Petersen DR
Toxicol Appl Pharmacol; 1999 Nov; 161(1):23-33. PubMed ID: 10558920
[TBL] [Abstract][Full Text] [Related]
5. Formation of liver microsomal MDA-protein adducts in mice with chronic dietary iron overload.
Valerio LG; Petersen DR
Toxicol Lett; 1998 Sep; 98(1-2):31-9. PubMed ID: 9776559
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation and protein modification in a mouse model of chronic iron overload.
Sochaski MA; Bartfay WJ; Thorpe SR; Baynes JW; Bartfay E; Lehotay DC; Liu PP
Metabolism; 2002 May; 51(5):645-51. PubMed ID: 11979400
[TBL] [Abstract][Full Text] [Related]
7. Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase.
Chen J; Petersen DR; Schenker S; Henderson GI
Alcohol Clin Exp Res; 2000 Apr; 24(4):544-52. PubMed ID: 10798592
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury.
Sampey BP; Korourian S; Ronis MJ; Badger TM; Petersen DR
Alcohol Clin Exp Res; 2003 Jun; 27(6):1015-22. PubMed ID: 12824824
[TBL] [Abstract][Full Text] [Related]
9. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
10. In situ detection of lipid peroxidation by-products in chronic liver diseases.
Paradis V; Kollinger M; Fabre M; Holstege A; Poynard T; Bedossa P
Hepatology; 1997 Jul; 26(1):135-42. PubMed ID: 9214462
[TBL] [Abstract][Full Text] [Related]
11. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
Paradis V; Mathurin P; Kollinger M; Imbert-Bismut F; Charlotte F; Piton A; Opolon P; Holstege A; Poynard T; Bedossa P
J Clin Pathol; 1997 May; 50(5):401-6. PubMed ID: 9215123
[TBL] [Abstract][Full Text] [Related]
12. Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene.
Wang G; Ansari GA; Khan MF
J Toxicol Environ Health A; 2007 Dec; 70(23):1977-85. PubMed ID: 17966069
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron overload.
Parkkila S; Niemelä O; Britton RS; Brown KE; Ylä-Herttuala S; O'Neill R; Bacon BR
Am J Physiol; 1996 Feb; 270(2 Pt 1):G376-84. PubMed ID: 8779982
[TBL] [Abstract][Full Text] [Related]
14. U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts.
Rohn TT; Nelson LK; Waeg G; Quinn MT
Biochem Pharmacol; 1998 Nov; 56(10):1371-9. PubMed ID: 9825737
[TBL] [Abstract][Full Text] [Related]
15. Adduct formation of 4-hydroxynonenal and malondialdehyde with elongation factor-2 in vitro and in vivo.
Argüelles S; Machado A; Ayala A
Free Radic Biol Med; 2009 Aug; 47(3):324-30. PubMed ID: 19447174
[TBL] [Abstract][Full Text] [Related]
16. Malondialdehyde-protein adducts in the spleens of aniline-treated rats: immunochemical detection and localization.
Khan MF; Wu X; Ansari GA; Boor PJ
J Toxicol Environ Health A; 2003 Jan; 66(1):93-102. PubMed ID: 12587293
[TBL] [Abstract][Full Text] [Related]
17. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration.
Tuma DJ; Thiele GM; Xu D; Klassen LW; Sorrell MF
Hepatology; 1996 Apr; 23(4):872-80. PubMed ID: 8666344
[TBL] [Abstract][Full Text] [Related]
18. Hepatic lipid peroxidation in vivo in rats with chronic iron overload.
Bacon BR; Tavill AS; Brittenham GM; Park CH; Recknagel RO
J Clin Invest; 1983 Mar; 71(3):429-39. PubMed ID: 6826715
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload.
Houglum K; Bedossa P; Chojkier M
Am J Physiol; 1994 Nov; 267(5 Pt 1):G908-13. PubMed ID: 7977754
[TBL] [Abstract][Full Text] [Related]
20. Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats.
Brunet S; Thibault L; Delvin E; Yotov W; Bendayan M; Levy E
Hepatology; 1999 Jun; 29(6):1809-17. PubMed ID: 10347124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]